The following video is part of our daily MarketFoolery podcast, in which host Chris Hill and analysts Alex Scherer and Jason Moser discuss business and investing news. In this segment, the guys discuss how big pharmaceutical companies are trying to overcome the rise of generic drugs, how intermediary players like CVS and Walgreen are benefiting, and which smaller pharmaceutical companies could be acquisition targets.
Chris Hill owns shares of Pfizer. The Motley Fool owns shares of National Oilwell Varco and Exelixis. Motley Fool newsletter services have recommended buying shares of Exelixis, Pfizer, and National Oilwell Varco. Try any of our Foolish newsletter services free for 30 days. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.